Physicians Realty Trust(DOC) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - For Q4 2025, the company reported FFO as adjusted of $0.47 per share and AFFO of $0.40 per share, with total same-store cash NOI growth of 3.9% [15] - For the full year 2025, FFO as adjusted was $1.84 per share and AFFO was $1.69 per share, with total same-store cash NOI growth of 4% [16] - The company ended the year with a net debt to Adjusted EBITDA ratio of 5.2x and $2.4 billion in liquidity [19] Business Line Data and Key Metrics Changes - Outpatient Medical segment represented over 50% of portfolio income, achieving same-store growth of 3.9% and 91% total occupancy [4][16] - The lab segment ended the year with 1.5% same-store growth and total occupancy of 77%, impacted by the Gateway acquisition [17] - Senior Housing segment reported 12.6% same-store growth, significantly above guidance, with 16.7% growth in Q4 [18] Market Data and Key Metrics Changes - The Bay Area led all Life Science markets in Q4 2025 in absorption and leasing activity, with the largest volume of current tenant demand [8] - The private market is recognizing the favorable operating environment, driving down cap rates [5] Company Strategy and Development Direction - The merger with Physicians Realty Trust has created a strong platform in the Outpatient sector, allowing for profitable internalization of property management [4] - The company is focusing on strategic acquisitions, including a 1.4 million sq ft campus in South San Francisco, to capitalize on recovery in the sector [8] - Plans to create a pure-play Senior Housing REIT through the Janus Living IPO, contributing the entire Senior Housing portfolio to capture value [10][11] Management's Comments on Operating Environment and Future Outlook - Management noted an inflection point in the Life Science sector, with signs of recovery in capital raising and M&A activity [6] - The company expects FFOs adjusted to range from $1.70-$1.74 per share for 2026, with same-store NOI growth forecasted between -1% to +1% [19] - Management expressed optimism about improving occupancy in the lab segment, contingent on favorable capital market conditions [30] Other Important Information - The company has completed $464 million in acquisitions so far in 2026, including a $314 million buyout of a joint venture partner in the Senior Housing portfolio [21] - The company plans to execute a capital recycling plan of $1 billion or more in asset sales and recapitalizations in 2026 [21] Q&A Session Summary Question: Can you discuss the Gateway acquisition and its complement to the existing portfolio? - Management expressed excitement about the Gateway acquisition, viewing it as an opportunity rather than a vacancy issue, and highlighted the strategic fit within their existing footprint [25][26] Question: What is the expected cadence of lab occupancy throughout the year? - Management indicated that total occupancy should improve by year-end 2026, depending on continued positive trends in capital markets [30] Question: Can you provide more details on the lab leasing activity? - Management noted that the pipeline is strong, with a mix of new leasing and renewals, and emphasized a significant improvement compared to the previous year [36] Question: What is the impact of lab occupancy losses on 2026 FFO? - Management clarified that the $0.12 impact on earnings is due to various factors, including occupancy losses and higher refinancing costs [41] Question: How are negotiations for 2026 expirations progressing? - Management reported that a substantial majority of expirations are in South San Francisco, where they have strong tenant relationships, and they are optimistic about renewals [61]